US 9353124
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
granted A61PA61P13/12A61P17/06
Quick answer
US patent 9353124 (Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P13/12, A61P17/06, A61P19/00, A61P19/02